Geneesmiddelenbeleid
This procedure is a motion focused on the pharmaceutical policy of the Netherlands. It aims to address how medicines are managed, priced, or accessed within the national healthcare system to ensure public health needs are met. This affects healthcare providers, pharmaceutical companies, and patients by potentially altering how drugs are regulated or funded in the Netherlands.
National vote coverage: Netherlands-only